Published 14 days ago

Weight loss drug could help treat sleep apnea: Study

Treating obstructive sleep apnea with a type 2 diabetes medication may offer new hope for sufferers, as indicated by a study released on Friday.
Tirzepatide resulted in a significant decrease in breathing interruptions during sleep, showing promise as a remedy for sleep apnea.
Those on tirzepatide showed improvement to potentially not needing CPAP, suggesting combined drug therapy for sleep apnea and obesity may offer greater benefits.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

The Guardian

Weight loss drug could ease sleep apnoea in people with obesity, study says

Research raises possibility that tirzepatide could become first pharmaceutical treatment for the sleeping disorderA drug used for type 2 diabetes and weight loss could reduce the severity of obstructive sleep apnoea (OSA) in people with obesity, research suggests, raising the possibility of the first pharmaceutical treatment for the condition.Tirzepatide, which is made by Eli Lilly and Company, together with other medications such as Wegovy from…

14 days ago·London, United Kingdom

Read Full Article

Associated Press News

Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds.Tirzepatide, the

14 days ago·United States

Read Full Article

abc News

Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea

A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep

14 days ago·United States

Read Full Article

KRDO

Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea

By JONEL ALECCIA AP Health Writer A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep. The research found that people who took tirzepatide reduced the number of episodes per hour in which their breathing slowed or stopped completely while they slept by about half to nearly 60%. The study published Friday was paid for by Eli Lilly, the drug’s maker. …

14 days ago·Colorado Springs, United States

Read Full Article

KVIA

Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea

14 days ago·Panama City, United States

Read Full Article

The Hill

Weight loss drug could help treat sleep apnea: Study

Patients who took the drug had their number of sleep apnea episodes reduced by about half to nearly 60 percent compared to just 10 percent who received a placebo.

14 days ago·Washington, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year